Literature DB >> 22753680

The search for diagnostic markers in sepsis: many miles yet to go.

Carolyn S Calfee, Jérôme Pugin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22753680      PMCID： PMC3400993          DOI： 10.1164/rccm.201205-0854ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  14 in total

Review 1.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

2.  Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.

Authors:  Allan S Brett; Richard J Ablin
Journal:  N Engl J Med       Date:  2011-10-26       Impact factor: 91.245

Review 3.  Management of sepsis.

Authors:  James A Russell
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 4.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

Authors:  Benjamin M P Tang; Guy D Eslick; Jonathan C Craig; Anthony S McLean
Journal:  Lancet Infect Dis       Date:  2007-03       Impact factor: 25.071

5.  Combination biomarkers to diagnose sepsis in the critically ill patient.

Authors:  Sébastien Gibot; Marie C Béné; Robin Noel; Frédéric Massin; Julien Guy; Aurélie Cravoisy; Damien Barraud; Marcelo De Carvalho Bittencourt; Jean-Pierre Quenot; Pierre-Edouard Bollaert; Gilbert Faure; Pierre-Emmanuel Charles
Journal:  Am J Respir Crit Care Med       Date:  2012-04-26       Impact factor: 21.405

6.  Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients.

Authors:  Bruce H Davis; Stephen H Olsen; Ejaz Ahmad; Nancy C Bigelow
Journal:  Arch Pathol Lab Med       Date:  2006-05       Impact factor: 5.534

7.  Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Authors:  Jens U Jensen; Lars Hein; Bettina Lundgren; Morten H Bestle; Thomas T Mohr; Mads H Andersen; Klaus J Thornberg; Jesper Løken; Morten Steensen; Zoe Fox; Hamid Tousi; Peter Søe-Jensen; Anne Ø Lauritsen; Ditte Strange; Pernille L Petersen; Nanna Reiter; Søren Hestad; Katrin Thormar; Paul Fjeldborg; Kim M Larsen; Niels E Drenck; Christian Ostergaard; Jesper Kjær; Jesper Grarup; Jens D Lundgren
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

8.  Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker.

Authors:  Vineet Bhandari; Chao Wang; Christine Rinder; Henry Rinder
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

9.  Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

Authors:  Vandack Nobre; Stephan Harbarth; Jean-Daniel Graf; Peter Rohner; Jérôme Pugin
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

10.  Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.

Authors:  Kristian Kofoed; Ove Andersen; Gitte Kronborg; Michael Tvede; Janne Petersen; Jesper Eugen-Olsen; Klaus Larsen
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more
  5 in total

1.  Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?

Authors:  Jordi Rello; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

2.  Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults.

Authors:  Hector R Wong; Kathleen D Liu; Kirsten N Kangelaris; Patrick Lahni; Carolyn S Calfee
Journal:  J Crit Care       Date:  2014-04-18       Impact factor: 3.425

3.  Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care.

Authors:  Avital Avriel; Maya Paryente Wiessman; Yaniv Almog; Yael Perl; Victor Novack; Ori Galante; Moti Klein; Michael J Pencina; Amos Douvdevani
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

4.  Thymoquinone modulates the expression of sepsis-related microRNAs in a CLP model.

Authors:  Khalid M Alkharfy; Ajaz Ahmad; Basit L Jan; Mohammad Raish; Muneeb U Rehman
Journal:  Exp Ther Med       Date:  2022-04-14       Impact factor: 2.447

5.  Metabolomic derangements are associated with mortality in critically ill adult patients.

Authors:  Angela J Rogers; Michael McGeachie; Rebecca M Baron; Lee Gazourian; Jeffrey A Haspel; Kiichi Nakahira; Laura E Fredenburgh; Gary M Hunninghake; Benjamin A Raby; Michael A Matthay; Ronny M Otero; Vance G Fowler; Emanuel P Rivers; Christopher W Woods; Stephen Kingsmore; Ray J Langley; Augustine M K Choi
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.